Atenolol and Chlorthalidone NDC 0591-5783

NDC codes

FDA NDC Directory

Product NDC (as listed)0591-5783Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00591-5783Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0591-5783-01	00591578301	100 TABLET in 1 BOTTLE (0591-5783-01)Marketed from Aug 1, 1992

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atenolol and Chlorthalidone
Generic name (nonproprietary): atenolol and chlorthalidone
Active ingredients: Atenolol — 100 mg/1Chlorthalidone — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Actavis Pharma, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 073665
Marketing start: Aug 1, 1992
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)Increased Diuresis (Physiologic effect)
Identifiers: Product ID 0591-5783_ea2e1205-e570-4d89-bd7a-b5ec4022ababSPL ID ea2e1205-e570-4d89-bd7a-b5ec4022ababSPL set ID a6794dfa-adbb-491b-9d48-f89a44e866c5RxCUI 197382, 197383UNII Q0MQD1073Q, 50VV3VW0TIUPC 0305915782011
Pharmacologic class: Thiazide-like Diuretic; beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400591578301 followed by a unit qualifier and the quantity

Package 00591-5783-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 1, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Atenolol and chlorthalidone is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including atenolol and chlorthalidone. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 073665

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 073665
Product	Strength	Form · route	Labeler	Product NDC
Atenolol and Chlorthalidone	Atenolol 50 mg/1; Chlorthalidone 25 mg/1	TabletOral	Actavis Pharma, Inc.	0591-5782
Atenolol and Chlorthalidone	Atenolol 50 mg/1; Chlorthalidone 25 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	55289-993